Patient-derived organoids in gynaecological cancers: emerging tools for therapy and disease modelling.
Patient-derived organoids (PDOs) have emerged as physiologically relevant three-dimensional (3D) culture systems that closely mimic the molecular and histological features of the human endometrium and associated malignancies. Owing to their …